{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:29:25Z","timestamp":1773289765174,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1016\/s0891-5849(00)00333-6","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T17:19:59Z","timestamp":1027617599000},"page":"1771-1779","source":"Crossref","is-referenced-by-count":105,"title":["Immunological responses to oxidized LDL"],"prefix":"10.1016","volume":"28","author":[{"given":"Sohvi","family":"H\u00f6rkk\u00f6","sequence":"first","affiliation":[]},{"given":"Christoph J","family":"Binder","sequence":"additional","affiliation":[]},{"given":"Peter X","family":"Shaw","sequence":"additional","affiliation":[]},{"given":"Mi-Kyung","family":"Chang","sequence":"additional","affiliation":[]},{"given":"Gregg","family":"Silverman","sequence":"additional","affiliation":[]},{"given":"Wulf","family":"Palinski","sequence":"additional","affiliation":[]},{"given":"Joseph L","family":"Witztum","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0891-5849(00)00333-6_BIB1","series-title":"Chien, K","first-page":"458","article-title":"Lipoproteins, lipoprotein oxidation, and atherogenesis","author":"Steinberg","year":"1999"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB2","doi-asserted-by":"crossref","unstructured":"Newby, A. C.; Libby, P.; van der Wal A. C. Plaque instability\u2014the real challenge for atherosclerosis research in the next decade? [editorial]. Cardiovasc. Res. 41:321\u2013322; 1999.","DOI":"10.1016\/S0008-6363(98)00276-4"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB3","series-title":"Chien, K","first-page":"349","article-title":"Atherogenesis and inflammation","author":"Libby","year":"1999"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00041433-199710000-00009","article-title":"Cell-mediated immunity in atherosclerosis","volume":"8","author":"Hansson","year":"1997","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/clim.1998.4682","article-title":"Are immunological mechanisms relevant for the development of atherosclerosis? [editorial]","volume":"90","author":"Witztum","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB7","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.4049\/jimmunol.158.9.4029","article-title":"Disruption of T cell tolerance by directing a self antigen to macrophage-specific scavenger receptors","volume":"158","author":"Abraham","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB8","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.4049\/jimmunol.160.10.4869","article-title":"Modulation of T cell cytokine profiles and peptide-MHC complex availability in vivo by delivery to scavenger receptors via antigen maleylation","volume":"160","author":"Singh","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB9","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.94.5.1931","article-title":"Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages","volume":"94","author":"Mach","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0002-9440(10)65176-0","article-title":"CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells","volume":"155","author":"Meliaan","year":"1999","journal-title":"Am. J. Path."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-3083.1999.00559.x","article-title":"Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice","volume":"50","author":"Zhou","year":"1999","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB12","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1073\/pnas.92.11.4937","article-title":"Accumulation of plasma cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits","volume":"92","author":"Sohma","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB13","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1172\/JCI118174","article-title":"Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity","volume":"96","author":"Roselaar","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB14","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1172\/JCI117622","article-title":"Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet","volume":"94","author":"Fyfe","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/28204","article-title":"Reduction of atherosclerosis in mice by inhibition of CD40 signalling","volume":"394","author":"Mach","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB16","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1172\/JCI119892","article-title":"Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice","volume":"102","author":"Nicoletti","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB17","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1073\/pnas.92.3.821","article-title":"Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis","volume":"92","author":"Palinski","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB18","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1161\/01.ATV.18.12.1972","article-title":"Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes","volume":"18","author":"Freigang","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB19","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.ATV.16.8.1074","article-title":"Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits","volume":"16","author":"Ameli","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB20","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0735-1097(97)00366-5","article-title":"Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits","volume":"30","author":"Nilsson","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0021-9150(98)00015-X","article-title":"Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis","volume":"138","author":"George","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB22","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.ATV.12.7.789","article-title":"Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65","volume":"12","author":"Xu","year":"1992","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/01.ATV.19.3.505","article-title":"Enhanced fatty streak formation in C57BL\/6J mice by immunization with heat shock protein-65","volume":"19","author":"George","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB24","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1073\/pnas.94.9.4642","article-title":"T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse","volume":"94","author":"Dansky","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB25","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1172\/JCI119681","article-title":"The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E\u2212\/\u2212 mice","volume":"100","author":"Daugherty","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB26","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1161\/01.CIR.96.11.4095","article-title":"Roles of infectious agents in atherosclerosis and restenosis","volume":"96","author":"Libby","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB27","doi-asserted-by":"crossref","first-page":"S444","DOI":"10.1016\/S0002-8703(99)70272-3","article-title":"Autoimmunity and atherosclerosis","volume":"138","author":"Wick","year":"1999","journal-title":"Am. Heart J."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.ATV.15.5.571","article-title":"Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits","volume":"15","author":"Palinski","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB29","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/01.ATV.17.10.2250","article-title":"Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice","volume":"17","author":"Reaven","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.ATV.20.1.10","article-title":"Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient nice","volume":"20","author":"Paulsson","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB31","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1073\/pnas.92.9.3893","article-title":"T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein","volume":"92","author":"Stemme","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB32","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1073\/pnas.81.10.3204","article-title":"Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus","volume":"81","author":"Witztum","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB33","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0022-2275(20)37720-8","article-title":"Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation","volume":"25","author":"Steinbrecher","year":"1984","journal-title":"J. Lipid Res."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB34","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1073\/pnas.86.4.1372","article-title":"Low density lipoprotein undergoes oxidative modification in vivo","volume":"86","author":"Palinski","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/01.ATV.10.3.325","article-title":"Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein","volume":"10","author":"Palinski","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB36","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI118854","article-title":"Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein","volume":"98","author":"H\u00f6rkk\u00f6","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB37","doi-asserted-by":"crossref","first-page":"10356","DOI":"10.1073\/pnas.94.19.10356","article-title":"The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins)","volume":"94","author":"H\u00f6rkk\u00f6","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB38","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S0022-2275(20)38576-X","article-title":"Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100","volume":"28","author":"Fong","year":"1987","journal-title":"J. Lipid Res."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB39","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/01.ATV.10.3.336","article-title":"Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits","volume":"10","author":"Rosenfeld","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB40","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/01.ATV.14.4.605","article-title":"ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde- lysine in serum","volume":"14","author":"Palinski","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB41","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1172\/JCI114271","article-title":"Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man","volume":"84","author":"Yl\u00e4-Herttuala","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.ATV.14.1.32","article-title":"Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL","volume":"14","author":"Yl\u00e4-Herttuala","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB43","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/01.ATV.15.10.1569","article-title":"Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis","volume":"15","author":"Palinski","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0531-5565(99)00037-6","article-title":"Lipoprotein modification and atherosclerosis in aging","volume":"34","author":"Reaven","year":"2000","journal-title":"Exp. Gerentol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB45","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1172\/JCI5897","article-title":"Disruption of the 12\/15 lipoxygenase gene diminishes atherosclerosis in apolipoprotein E-deficient mice","volume":"103","author":"Cyrus","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB46","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0140-6736(92)90926-T","article-title":"Autoantibody against oxidised LDL and progression of carotid atherosclerosis","volume":"339","author":"Salonen","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1365-2796.2000.00656.x","article-title":"Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atheroscleosis","volume":"247","author":"Palinski","year":"2000","journal-title":"J. Intern. Med."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00041433-199808000-00009","article-title":"Is oxidized low-density lipoprotein present in vivo?","volume":"9","author":"Yl\u00e4-Herttuala","year":"1998","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB49","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1172\/JCI118853","article-title":"Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma","volume":"98","author":"Palinski","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI4533","article-title":"Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins","volume":"103","author":"H\u00f6rkk\u00f6","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB51","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1073\/pnas.96.11.6347","article-title":"Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties","volume":"96","author":"Bird","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB52","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0022-2275(20)38623-5","article-title":"Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits","volume":"28","author":"Wiklund","year":"1987","journal-title":"J. Lipid Res."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB53","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.ATV.12.11.1258","article-title":"Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates","volume":"12","author":"Khoo","year":"1992","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB54","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1073\/pnas.92.5.1396","article-title":"Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages","volume":"92","author":"Sambrano","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB55","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1073\/pnas.96.11.6353","article-title":"Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages","volume":"96","author":"Chang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB56","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(94)92639-5","article-title":"Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein [see comments]","volume":"343","author":"Branch","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB57","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1073\/pnas.97.4.1743","article-title":"Cardiolipin is a normal component of human plasma lipoproteins","volume":"97","author":"Deguchi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB58","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood.V90.10.3931","article-title":"Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies","volume":"90","author":"Iuliano","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB59","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1182\/blood.V93.10.3401.410k36_3401_3407","article-title":"Ongoing prothrombotic state in patients with antiphospholipid antibodies","volume":"93","author":"Pratic\u00f2","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.CIR.91.1.23","article-title":"Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men","volume":"91","author":"Vaarala","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB61","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1161\/01.ATV.17.11.3159","article-title":"Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction","volume":"17","author":"Wu","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0167-5699(95)80068-9","article-title":"Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases","volume":"16","author":"Liblau","year":"1995","journal-title":"Immunol. Today"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB63","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"},{"key":"10.1016\/S0891-5849(00)00333-6_BIB64","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1172\/JCI1216","article-title":"Hypercholesterolemia is associated with a T helper (Th) 1\/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice","volume":"101","author":"Zhou","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB65","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.ATV.19.3.734","article-title":"The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice","volume":"19","author":"Lee","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB66","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","article-title":"IFN-gamma potentiates atherosclerosis in ApoE knock-out mice","volume":"99","author":"Gupta","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB67","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1172\/JCI119564","article-title":"Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts","volume":"100","author":"Nagano","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB68","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1161\/01.RES.85.8.e17","article-title":"Protective role of interleukin-10 in atherosclerosis","volume":"85","author":"Mallat","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB69","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1161\/01.ATV.19.12.2847","article-title":"Interleukin-10 blocks atherosclerotic events in vitro and in vivo","volume":"19","author":"Pinderski Oslund","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB70","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.178.3.1041","article-title":"Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor\/IL-12 synthesis in accessory cells","volume":"178","author":"D\u2019Andrea","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0891-5849(00)00333-6_BIB71","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1172\/JCI118650","article-title":"Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis","volume":"97","author":"Uyemura","year":"1996","journal-title":"J. Clin. Invest."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584900003336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584900003336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T22:53:00Z","timestamp":1681167180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584900003336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":71,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S0891584900003336"],"URL":"https:\/\/doi.org\/10.1016\/s0891-5849(00)00333-6","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}